Mason Carrico
Stock Analyst at Stephens & Co.
(1.23)
# 2,695
Out of 4,479 analysts
45
Total ratings
35.48%
Success rate
-12.84%
Average return
Main Sectors:
13 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HOLX Hologic | Initiates: Overweight | $87 | $73.53 | +18.32% | 1 | Jun 27, 2024 | |
| GH Guardant Health | Reiterates: Overweight | $44 | $28.87 | +52.41% | 4 | May 24, 2024 | |
| CDNA CareDx | Maintains: Overweight | $15 → $18 | $14.90 | +20.81% | 8 | May 13, 2024 | |
| ILMN Illumina | Reiterates: Overweight | $170 | $105.51 | +61.12% | 4 | May 7, 2024 | |
| OCX OncoCyte | Reiterates: Equal-Weight | $4 | $2.96 | +35.14% | 3 | Apr 17, 2024 | |
| NTRA Natera | Reiterates: Overweight | $78 | $110.70 | -29.54% | 3 | Jan 30, 2024 | |
| PACB Pacific Biosciences of California | Initiates: Overweight | $11 | $1.28 | +759.38% | 1 | Dec 14, 2023 | |
| CTKB Cytek Biosciences | Initiates: Overweight | $9 | $5.60 | +60.71% | 1 | Dec 14, 2023 | |
| AKYA Akoya Biosciences | Maintains: Overweight | $14 → $9 | $2.18 | +312.84% | 4 | Nov 13, 2023 | |
| VCYT Veracyte | Reiterates: Overweight | $34 | $21.26 | +59.92% | 5 | Oct 10, 2023 | |
| CSTL Castle Biosciences | Reiterates: Overweight | $37 | $21.26 | +74.04% | 5 | Jul 6, 2023 | |
| TXG 10x Genomics | Reiterates: Overweight | $65 | $18.87 | +244.46% | 3 | May 18, 2023 | |
| MYGN Myriad Genetics | Reiterates: Equal-Weight | $24 | $24.76 | -3.07% | 3 | May 4, 2023 |
Hologic
Jun 27, 2024
Initiates: Overweight
Price Target: $87
Current: $73.53
Upside: +18.32%
Guardant Health
May 24, 2024
Reiterates: Overweight
Price Target: $44
Current: $28.87
Upside: +52.41%
CareDx
May 13, 2024
Maintains: Overweight
Price Target: $15 → $18
Current: $14.90
Upside: +20.81%
Illumina
May 7, 2024
Reiterates: Overweight
Price Target: $170
Current: $105.51
Upside: +61.12%
OncoCyte
Apr 17, 2024
Reiterates: Equal-Weight
Price Target: $4
Current: $2.96
Upside: +35.14%
Natera
Jan 30, 2024
Reiterates: Overweight
Price Target: $78
Current: $110.70
Upside: -29.54%
Pacific Biosciences of California
Dec 14, 2023
Initiates: Overweight
Price Target: $11
Current: $1.28
Upside: +759.38%
Cytek Biosciences
Dec 14, 2023
Initiates: Overweight
Price Target: $9
Current: $5.60
Upside: +60.71%
Akoya Biosciences
Nov 13, 2023
Maintains: Overweight
Price Target: $14 → $9
Current: $2.18
Upside: +312.84%
Veracyte
Oct 10, 2023
Reiterates: Overweight
Price Target: $34
Current: $21.26
Upside: +59.92%
Castle Biosciences
Jul 6, 2023
Reiterates: Overweight
Price Target: $37
Current: $21.26
Upside: +74.04%
10x Genomics
May 18, 2023
Reiterates: Overweight
Price Target: $65
Current: $18.87
Upside: +244.46%
Myriad Genetics
May 4, 2023
Reiterates: Equal-Weight
Price Target: $24
Current: $24.76
Upside: -3.07%